The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASLR.L Regulatory News (ASLR)

  • There is currently no data for ASLR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Subscription

18 Mar 2021 07:00

RNS Number : 6385S
Asimilar Group PLC
18 March 2021
 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018).

 

18 March 2021

 

 

ASIMILAR GROUP PLC ('ASIMILAR' OR 'THE COMPANY')

 

Completion of Subscription

 

 

Further to the announcement of 1 March 2021, Asimilar Group plc (AIM: ASLR), the AIM quoted investment company focused on technology opportunities in the fields of big data, machine learning, telematics and the Internet of Things (IoT), notes the announcement today by Dev Clever Holdings plc ("Dev Clever") that it has published a prospectus dated 17 March 2021.

 

Accordingly the subscription by the Company's wholly owned subsidiary, Intrinsic Capital Jersey Limited ("ICJL"), for 30 million ordinary shares in Dev Clever at 10 pence per share will now proceed, with completion expected to occur on or around 23 March 2021 when the new ordinary shares in Dev Clever are admitted to trading.

 

On completion of the subscription, Asimilar will have an interest in 70 million ordinary shares in Dev Clever representing approximately 12.2 per cent. of Dev Clever's issued share capital. In addition to the 70 million ordinary shares, Asimilar retains a warrant to subscribe for 35 million new ordinary shares in Dev Clever at 25 pence per Dev Clever share.

 

Commenting on the completion of subscription, John Taylor, Non-Executive Chairman of Asimilar, said: "The successful completion of this subscription, with the share price of Dev Clever now trading at a significant premium to our entry price, demonstrates our ability to spot exciting opportunities and ensures we are able to benefit from their future growth.

 

"We remain excited by the future prospects of a number of our other investments and will update shareholders, as appropriate, in due course."

 

-ends-

 

 

For further information please contact:

 

 

 

 

Asimilar Group plc

 

 

John Taylor, Non-Executive Chairman

via Buchanan

 

 

 

 

Cairn Financial Advisers LLP

 

 

Sandy Jamieson / Liam Murray

Tel: +44 20 7213 0880

 

 

 

 

Peterhouse Capital Limited

 

 

Duncan Vasey / Lucy Williams

Tel: + 44 20 7220 9797

 

 

 

 

Buchanan Communications Limited

 

 

Richard Oldworth / Chris Lane

Tel: +44 (0) 20 7466 5000

     

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURFDLLFFXLEBBK
Date   Source Headline
23rd Jun 20087:00 amRNSInterim Results
9th Jun 200812:00 pmRNSContract Win
19th Mar 20082:29 pmRNSDirector/PDMR Shareholding
17th Mar 20082:22 pmRNSPosting of annual report
29th Feb 20087:01 amRNSContract gains
27th Feb 20089:27 amRNSHolding(s) in Company
26th Feb 20081:58 pmRNSDirector/PDMR Shareholding
25th Feb 20082:21 pmRNSAGM Statement
6th Feb 20087:01 amRNSAdditional Listing & Placing
31st Jan 20083:35 pmRNSFinal Results
6th Nov 20075:40 pmRNSDirectorate Change
15th Oct 20077:00 amRNSBlue chips trial product
8th Oct 20077:01 amRNSSignificant contract gain
28th Sep 20077:02 amRNSContract Gains
21st Sep 20077:01 amRNSSignificant contract gain
10th Sep 20077:02 amRNSPrivate Placing
17th Aug 20079:07 amRNSRule 26 compliance
13th Aug 20077:00 amRNSContract gains
6th Aug 20077:00 amRNSNew distributor
29th Jun 20077:01 amRNSInterim Results
22nd Jun 20077:01 amRNSContract gains
15th Jun 20077:01 amRNSContract gain
23rd May 20077:01 amRNSBoard Change
14th May 200711:22 amRNSAGM Statement
11th May 20077:01 amRNSNew product launch
23rd Apr 20077:02 amRNSAppointment of Distributors
20th Apr 20075:47 pmRNSDirector/PDMR Shareholding
19th Apr 20077:01 amRNSContract gain
4th Apr 20077:03 amRNSGrowing presence in the USA
29th Mar 200712:15 pmRNSFinal Results
19th Jan 200711:29 amRNSTotal Voting Rights
22nd Dec 200610:06 amRNSTotal Voting Rights
6th Dec 20066:41 pmRNSIssue of Equity
10th Nov 20067:00 amRNSRe Contract
3rd Nov 20067:00 amRNSRe Contract
27th Oct 20067:01 amRNSRe Contract
26th Sep 20061:10 pmRNSIssue of Equity
22nd Sep 20067:00 amRNSContract wins
31st Jul 20067:00 amRNSContract gain
24th Jul 20067:01 amRNSInvestment
15th Jun 20063:05 pmRNSIssue of Equity
14th Jun 20067:01 amRNSInterim Results
6th Jun 20067:01 amRNSContract gain
15th May 200611:37 amRNSDisposal
18th Apr 20067:01 amRNSBoard changes
31st Mar 20063:36 pmRNSAnnual Report and Accounts
31st Mar 200610:37 amRNSFinal Results
24th Feb 20067:00 amRNSCompany Restructure
8th Dec 20057:00 amRNSBahrain office & contract win
25th Nov 20057:00 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.